Newgen Software Technologies Limited has recently announced three significant contracts—two with international clients (USA and Singapore) and one domestic order in India. These agreements highlight the company’s growing global footprint and expertise in software solutions.
Newgen’s International Contract in the USA
- Agreement Details: Newgen’s US subsidiary (Newgen Software Inc.) secured a contract worth $1.27 million with an international client.
- Execution Time Frame: The project will be completed in 3 years.
Newgen’s International Contract in Singapore
- Agreement Details: Newgen’s Singapore subsidiary signed a deal worth S$1.58 million with an international customer.
- Execution Time Frame: To be delivered in 3 years.
Newgen’s Domestic Order in India
- Order Details: The parent company (Newgen Software Technologies Ltd.) received a domestic purchase order worth ₹35.30 crore (inclusive of taxes) for a Centralised Trade Finance (CTF) solution.
- Scope: Includes supply, implementation, integration and maintenance of the CTF system and a customer web portal.
- Execution Time Frame: 5 years.
Significance of These Contracts
- Global Expansion: Strengthens Newgen’s presence in international markets (USA, Singapore).
- Domestic Growth: Major ₹35.3 crore order boosts its Indian portfolio.
Share performance
As of April 01, 2025, at 11:25 AM, Newgen Software Technologies’ share price is trading at ₹991.05 per share, reflecting a loss of 0.53% from the previous closing price. Over the past month, the stock has registered a profit of 4.86%. The stock’s 52-week high stands at ₹1,798.90 per share, while its low is ₹724.10 per share.
Conclusion
These contracts reinforce Newgen’s strong market presence in both domestic and international markets. The timely disclosures reflect transparency, boosting investor confidence while supporting the company’s expansion in the tech industry.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.